Rongelap 40 HOSPITAL OF THE MEDICAL RESEARCH CENTER, BROOKHAVEN NATIONAL LABORATORY (NAME) UPTON, NEW YORK 11973 08-45-42R Aree Code 516 YAphank 4~6262 (UNIT NO.) DISCHARGE SUMMARY COURSE CONTIUED: time of discharge on June 10th, he was symptom free and his thyroid of normal size. cause of this episode is unclear. The AT the Metropolitan General Dr. Brown Dobyns. Hospital thyroid surgery was performed by 25 microcuries of 131 iodine were given orally the day before for autoradiographic studies of removed thyroid tissues. In surgery a firm area waa noted at the junction of the right lobe and isthmus which contained several small nodules and also several areas of nodularity were noted in isthmus. The lower part of the isthms and part of the right lobe were removed. The pathologist reported the lesions benign with varying degrees of hyperthrophy, hyperplasia and fibrosis. The patient withstood the surgery well and his convalescence was uneventful. He waa discharged on June 18th to return to the Marshall Islands. Copies of the Hospital Summary and Pathological Reports from Cleveland incorporated with the BNL records. PIAGNOSIS: MEDICATION: Thyroid lobular hyperplasia and hypertrophy with slight fibrosis. Continued treatment with L-thyroxin (3 MG- day) is recommended since he is part of the more heavily exposed Rongelap group, all of whom have been placed on such treatment since 1965. Kiker? <7 Ceme~ Se Received: Typed: er Robert A. Conard, M.D. 6*28-73 6-29-73 OM 720A - 123 -